Target intelligence / Profile preview

Ovarian inflammatory and intracellular signaling pathways

Molecular classification
Other, Biological Pathway
01

Overview

Ovarian inflammatory and intracellular signaling pathways encompass a broad array of molecular networks that govern essential reproductive processes, including oocyte maturation, ovulation, and corpus luteum formation (Duffy et al., 2019, PMID: 30541137). These pathways, such as the NF-κB, PI3K/Akt/mTOR, and MAPK/ERK cascades, integrate signals from gonadotropins and local growth factors to maintain ovarian homeostasis. Chronic activation or dysregulation of these inflammatory signals is a hallmark of conditions like polycystic ovary syndrome (PCOS), where they contribute to insulin resistance and hyperandrogenism (Gonzalez, 2012, PMID: 22222341). In the context of oncology, aberrant signaling within these pathways drives the proliferation and survival of ovarian cancer cells (Ghoneum et al., 2020, PMID: 32824581). Because this term describes a collection of processes rather than a single protein, it is not considered a discrete therapeutic target, though many of its constituent molecules are targeted by specific drugs.

Other names
Ovarian signaling cascadesIntra-ovarian inflammatory pathwaysOvarian intracellular signaling
02

Mechanism of action

Modulation of intracellular cascades such as PI3K/Akt, MAPK, and NF-κB to regulate follicular growth, steroidogenesis, and inflammatory cytokine production.

03

Biological functions

Signal transductionImmune responseCell proliferationApoptosisOvulationSteroidogenesis
04

Disease associations

Polycystic ovary syndrome (PCOS)Ovarian cancerEndometriosisInfertilityPremature ovarian failure
05

Safety considerations

Systemic immunosuppressionDisruption of normal menstrual cycleOff-target effects in non-ovarian tissuesPotential teratogenicity
06

Interacting drugs

Metformin

4 more in the full profile.

07

Biomarkers

Interleukin-6 (IL-6)Tumor necrosis factor-alpha (TNF-α)C-reactive protein (CRP)Anti-Müllerian hormone (AMH)Androstenedione

Beyond the preview

Go deeper on Ovarian inflammatory and intracellular signaling pathways.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ovarian inflammatory and intracellular signaling pathways.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call